emcure pharmaceuticals limited

Emcure Pharmaceuticals Limited, incorporated in the early 1980s, is an Indian multinational pharmaceutical company headquartered in Pune. The company develops, manufactures, and markets a wide range of pharmaceutical products globally. Emcure's product portfolio includes tablets, capsules, and injectables, covering various therapeutic areas such as gynecology, cardiology, oncology, respiratory, CNS, and HIV. With over 350 brands, five R&D centers, and 13 manufacturing facilities in India, Emcure has a presence in over 70 countries. The company has launched six biologics in domestic and international markets and is a domestic leader in three. Satish Ramanlal Mehta serves as the Managing Director and Chief Executive Officer. Key collaborations include agreements with Bristol-Myers Squibb and Gilead Sciences for AIDS drugs, and Roche for manufacturing cancer drugs in India. Emcure's vertically integrated supply chain, including API facilities, ensures manufacturing flexibility.